摘要
对比2018年1月美国肝病学会《肝细胞癌治疗指南》及同年4月的指导文件,2018年欧洲肝病学会《肝细胞癌管理临床实践指南》,以及2018年我国临床肿瘤学会《原发性肝癌诊疗指南》在肝细胞癌监测、诊断、分期、治疗四方面的异同,总结得出:肝癌高危人群应接受每6个月1次的腹部B超监测,监测发现的肝脏结节应通过影像学或肝活检进一步诊断、随访。欧美指南沿用巴塞罗那分期作为肝癌的分期系统,我国制定了I-IV期的分期系统。近年来,对晚期肝癌全身治疗的研究,正成为国内外新的热点,本文重点做一综述,旨在为我国晚期肝癌的诊治提供借鉴。
This article makes a comparative analysis of the key recommendations in surveillance,diagnosis,staging and treatment for hepatocellular carcinoma(HCC)from the newest updated guidelines issued by American Association for the Study Liver Disease,European Association for the Study of Liver,and Chinese Society of Clinical Oncology,respectively.It is agreed that patients at high risk for developing HCC should undergo surveillance with ultrasound every six months.Detected hepatic nodules should be diagnosed and followed-up by further imaging examination or liver biopsy.The HCC staging system varies among different guidelines.The studies and clinical trials of system therapy in advanced HCC are becoming new highlights.
作者
李晓鹤
魏来
Li Xiaohe;Wei Lai(Peking University People’s Hospital,Peking University Hepatology Institute,Beijing Key Laboratory of Hepatitis C and Immunotherapy of Liver Diseases,Beijing 100044,China)
出处
《中华肝脏病杂志》
CAS
CSCD
北大核心
2019年第3期236-240,共5页
Chinese Journal of Hepatology
关键词
肝细胞癌
诊疗规范
综述
Hepatocellular carcinoma
Guidelines
Review
